TARGETING THE SCS CLEARSIDE BIOMEDICAL Trademark

Trademark Overview


On Tuesday, November 8, 2022, a trademark application was filed for TARGETING THE SCS CLEARSIDE BIOMEDICAL with the United States Patent and Trademark Office. The USPTO has given the TARGETING THE SCS CLEARSIDE BIOMEDICAL trademark a serial number of 97667367. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, September 25, 2024. This trademark is owned by Clearside Biomedical, Inc.. The TARGETING THE SCS CLEARSIDE BIOMEDICAL trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Ocular pharmaceuticals; Ophthalmic preparations

Medical devices, namely, a needle-based injection system for delivery of pharmaceutical preparations comprised of injection instruments with needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceutical preparations to eye tissue comprised of injection instruments with needles; Injection needles for suprachoroidal injections; Injection needles
targeting the scs clearside biomedical

General Information


Serial Number97667367
Word MarkTARGETING THE SCS CLEARSIDE BIOMEDICAL
Filing DateTuesday, November 8, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, September 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "TARGETING THE SCS CLEARSIDE BIOMEDICAL" in stylized letters stacked below a stylized rendering of the inside of a human eyeball featuring a stylized alignment target at the rear of the eyeball.
Pseudo MarkTARGETING THE SUPRACHOROIDAL SPACE CLEAR SIDE BIOMEDICAL
Goods and ServicesOcular pharmaceuticals; Ophthalmic preparations
Pseudo MarkTARGETING THE SCS CLEAR SIDE BIOMEDICAL
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"BIOMEDICAL"
Goods and ServicesMedical devices, namely, a needle-based injection system for delivery of pharmaceutical preparations comprised of injection instruments with needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceutical preparations to eye tissue comprised of injection instruments with needles; Injection needles for suprachoroidal injections; Injection needles

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, July 13, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameClearside Biomedical, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005

Party NameClearside Biomedical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAlpharetta, GA 30005

Trademark Events


Event DateEvent Description
Monday, November 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 11, 2022NEW APPLICATION ENTERED
Tuesday, November 29, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, May 16, 2023ASSIGNED TO EXAMINER
Tuesday, May 16, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 16, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 12, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 12, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 14, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 14, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 14, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, June 14, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 27, 2023WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, July 7, 2023PREVIOUS ALLOWANCE COUNT WITHDRAWN
Thursday, July 13, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, July 13, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 13, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, July 13, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, July 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 9, 2024SOU EXTENSION 1 FILED
Tuesday, April 9, 2024SOU EXTENSION 1 GRANTED
Wednesday, April 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 25, 2024SOU EXTENSION 2 GRANTED
Wednesday, September 25, 2024SOU EXTENSION 2 FILED